Afya (AFYA) to Release Earnings on Monday

Afya (NASDAQ:AFYAGet Rating) is scheduled to issue its quarterly earnings data after the market closes on Monday, May 23rd. Analysts expect the company to announce earnings of $0.26 per share for the quarter. Afya has set its FY 2022 guidance at EPS.Parties that are interested in participating in the company’s conference call can do so using this link.

Afya (NASDAQ:AFYAGet Rating) last posted its quarterly earnings results on Thursday, March 31st. The company reported $0.09 earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.02). The business had revenue of $89.29 million for the quarter, compared to analyst estimates of $94.35 million. Afya had a return on equity of 7.32% and a net margin of 12.94%. On average, analysts expect Afya to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

NASDAQ:AFYA opened at $11.63 on Monday. The company’s 50-day moving average is $13.85 and its two-hundred day moving average is $14.09. Afya has a 1-year low of $10.90 and a 1-year high of $28.23. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.57 and a quick ratio of 1.56. The firm has a market capitalization of $1.07 billion, a price-to-earnings ratio of 26.43, a PEG ratio of 0.59 and a beta of 1.08.

AFYA has been the subject of several analyst reports. Zacks Investment Research cut shares of Afya from a “buy” rating to a “hold” rating in a research note on Friday, May 6th. Credit Suisse Group raised shares of Afya from a “neutral” rating to an “outperform” rating and increased their price target for the company from $18.00 to $19.00 in a research note on Friday, April 8th. Finally, UBS Group dropped their price target on shares of Afya from $27.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, March 7th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $20.88.

Hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. acquired a new stake in Afya during the 1st quarter worth approximately $14,949,000. Deutsche Bank AG lifted its holdings in Afya by 8.8% during the 4th quarter. Deutsche Bank AG now owns 354,087 shares of the company’s stock worth $5,563,000 after buying an additional 28,500 shares in the last quarter. Marshall Wace LLP lifted its holdings in Afya by 2,250.0% during the 4th quarter. Marshall Wace LLP now owns 332,837 shares of the company’s stock worth $5,230,000 after buying an additional 318,674 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Afya by 2,298.0% in the 4th quarter. Invesco Ltd. now owns 292,556 shares of the company’s stock valued at $4,596,000 after purchasing an additional 280,356 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Afya in the 4th quarter valued at $2,668,000. Hedge funds and other institutional investors own 57.03% of the company’s stock.

Afya Company Profile (Get Rating)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Further Reading

Earnings History for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.